Lloyd Fisher to Heart Failure
This is a "connection" page, showing publications Lloyd Fisher has written about Heart Failure.
Connection Strength
0.447
-
Packer M, Pitt B, Rouleau JL, Swedberg K, DeMets DL, Fisher L. Long-Term Effects of Flosequinan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure: Primary Results of the PROFILE Trial After 24 Years. JACC Heart Fail. 2017 06; 5(6):399-407.
Score: 0.309
-
Anand IS, Florea VG, Fisher L. Surrogate end points in heart failure. J Am Coll Cardiol. 2002 May 01; 39(9):1414-21.
Score: 0.109
-
Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003 Mar 11; 107(9):1278-83.
Score: 0.029